- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The Advantage of True Cannabis Entrepreneurs
Overview
Chemistree Technology Inc. (CSE:CHM; OTC:CHMJF) is leveraging its management team’s decades of cannabis industry expertise to build a high-profile portfolio of vertically-integrated cannabis assets. Through strategic partnerships, Chemistree is creating a network of multi-state cannabis operations from cultivation and processing to distribution and retail. Beginning in Washington State and now entering the California market, the company is quickly expanding its reach with the goal of building a coast-to-coast empire in the US cannabis market.
Chemistree currently owns operational assets and branding rights for the Washington-based Sugarleaf brand, a 50 percent interest in a cannabis processing company in Humboldt County, prospective cannabis cultivation lands in southern California and has entered the Canadian cannabis sector through its investment in Pasha Brands. As part of the company’s expansion plans, Chemistree has moved into New Jersey by investing in Applies Cannabis Sciences of New Jersey, a vertically-integrated medical cannabis applicant. Chemistree has also acquired an ownership stake in The Physician’s Choice CBD, a hemp-derived CBD product developer. The new additions to Chemistree’s business are expected to help grow its Sugarleaf brand and product lines.
The Sugarleaf brand has an established foothold in the US cannabis industry. At the November 2018 MJBiz Conference in Las Vegas, Sugarleaf and Chemistree co-sponsored the High Times magazine party. The brand has also been featured on CustomGrow420’s 1.6 million subscriber YouTube channel and in Dope Magazine, one of the largest global media publications in the cannabis industry. Now that Chemistree has the global rights to the brand, the company is moving forward with plans to expand the facility’s canopy to increase output in order to support new product offerings and a much larger retail footprint.
Chemistree’s strategic partnership with a licensed processor in Humboldt County gives the Sugarleaf brand an attractive entry point into one of the world’s largest cannabis markets. Chemistree is providing both the capital and management depth needed to rapidly expand the processor’s business across the state of California and into new jurisdictions in the US.
In southern California, Chemistree’s subsidiary has been granted a conditional use permit (CUP) from the City of Desert Hot Springs—an oasis in the desert for California’s cannabis industry.
Chemistree’s most valuable asset is its management team. Some of the most respected leaders in cannabis along with highly successful entrepreneurs from other industries have brought their deep skillset and wealth of experience to benefit the company’s shareholders. Almost all of Chemistree’s founding members have successfully built $50 million companies, providing the team with the expertise and experience necessary to succeed in a highly-competitive industry.
Chemistree’s savvy management team lead the company to acquire Sugarleaf and its Tier 3 producer and processor license after the company was revealed to be in distress. By taking advantage of Sugarleaf’s early struggles, Chemistree was able to secure the company and its licenses for only US$1 million, a significant discount when compared to the shutdown value of its assets at the time.
Chemistree President Karl Kottmeier has two decades of experience in listing, financing and administering TSX and TSXV-listed companies. In that time, he has raised more than $150 million in equity capital.
Chemistree Company Highlights
- Vertically-integrated company expanding into premiere cannabis jurisdictions in the US and beyond.
- Team of true cannabis entrepreneurs with decades of experience in managing all aspects of profitable cannabis businesses including branding, cultivation, manufacturing and finance.
- Strong foothold in Washington State, a market with nearly 750,000 recreational cannabis consumers.
- Immediate access to one of the world’s biggest cannabis markets via California processor’s license for Sugarleaf-branded products.
- Granted CUP license at 9.55-acre Desert Hot Springs property.
- Plans in 2019 to increase cultivation yield at Sugarleaf facility, expand retail footprint, product offerings and develop Desert Hot Springs greenhouse cultivation facility.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.